|
⚲
|
| Keyboard |
| Aisling Capital III LP
✚
|
|
|---|---|
| CIK # | 0001444717 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001444717] | |
| 4 | [0001444717] | |
| 5 | [0001444717] | |
| SC 13D | [0001444717] | |
| SC 13G | [0001444717] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Loxo Oncology Inc LOXO
Common Stock
|
2018-07-10 | Sell | 1,400,000 | $179.43 | 251,202,000 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2017-12-19 | Sell | 250,000 | $80.50 | 20,125,000 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2017-11-22 | Sell | 500,000 | $75.00 | 37,500,000 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2017-01-10 | Buy | 160,000 | $31.00 | 4,960,000 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2016-07-06 | Buy | 400,000 | $12.50 | 5,000,000 |
|
Syros Pharmaceuticals Inc SYRS
Series B Preferred Stock · derivative
|
2016-07-06 | Conversion | 1,907,122 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2016-07-06 | Conversion | 508,565 | ||
|
Agile Therapeutics Inc AGRX
Common Stock
|
2016-06-02 | Other | 400,000 | $0.00 | |
|
Loxo Oncology Inc LOXO
Common Stock
|
2016-05-17 | Buy | 232,558 | $21.50 | 4,999,997 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2015-12-11 | Buy | 200 | $27.50 | 5,500 |
|
T2 Biosystems Inc TTOO
Common Stock
|
2015-12-09 | Buy | 307,692 | $9.75 | 2,999,997 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2015-11-17 | Buy | 265,000 | $26.50 | 7,022,500 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2015-11-13 | Buy | 1,955 | $27.47 | 53,704 |
|
Loxo Oncology Inc LOXO
Common Stock
|
2015-11-12 | Buy | 76,714 | $27.65 | 2,121,142 |
|
Aravive Inc VSAR
Common Stock
|
2015-01-27 | Buy | 145,000 | $17.25 | 2,501,250 |
|
Agile Therapeutics Inc AGRX
Common Stock
|
2015-01-23 | Buy | 811,966 | $5.85 | 4,750,001 |
|
T2 Biosystems Inc TTOO
Series D Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 2,967,033 | $0.00 | |
|
T2 Biosystems Inc TTOO
Common Stock
|
2014-08-12 | Conversion | 2,068,755 | $0.00 | |
|
T2 Biosystems Inc TTOO
Common Stock
|
2014-08-12 | Buy | 454,545 | $11.00 | 4,999,995 |
|
T2 Biosystems Inc TTOO
Series E Convertible Preferred Stock · derivative
|
2014-08-12 | Conversion | 549,851 | $0.00 | |
| showing 20 of 52 most recent transactions | |||||